On March 23, 2011, Colgate-Palmolive (CL) agreed to buy Unilever's (UL) Sanex brand of personal care products for $954 million. The deal also includes Colgate selling its laundry detergent business in Colombia to Unilever for $215 million. As of now, both transactions are subject to regulatory approval. These two companies compete with consumer Proctor & Gamble (PG), Avon (AVP) and Kimberly-Clark (KMB).

Headquartered in the Netherlands, Unilever (UL) is the second largest consumer goods company in the world after Procter & Gamble (PG) and sells everything from soaps and deodorants to salad dressings, ice-cream and tea beverages. Its portfolio of billion-dollar brands includes Dove, Lux, Axe, Rexona, Surf, CloseUp, Signal, Wall's, Lipton and Vaseline, to name a few.

Our price estimate for Unilever stands at $35.14, well ahead of market price.

A lot has been written about the slow pace of economic recovery in the U.S. with unemployment levels at close to historical highs at 9.4% (as of December 2010) set in contrast to the feverish growth of emerging markets. It then comes as no surprise that most of the big players in the beauty and personal care industry such as L'Oreal (LRLCY), Estee Lauder (EL), Revlon (REV), Avon (AVP), Procter & Gamble (PG), Unilever (UL), Colgate (CL) and Kimberly Clark (KMB) are increasing their presence in growing markets like China, India and Latin America.

U.S. stocks closed lower on Monday, with the Dow index falling 0.2%.

No major U.S. economic data are due to be released today.

In the midst of deep fear and melodramatic headlines in May, I dove into the market suggesting investors take a hard look at three companies that would survive anything the world could throw at them.

There are often profits to be made from the headlines as fear and greed drive the market. You must have read umpteen times in journals worldwide "my pal Warren's" trumpeting smart investors to buy on fear. Well, last may Novartis AG ADS (NVS), Telefonica SA (TEF) and Unilever ADR (UL) were on sale as fear ruled the day. So let's see how these ideas worked out.

Analyst Upgrades

• Credit Suisse upgraded Alliant Techsystems (ATK) to outperform from neutral following the company's increased FY11 guidance. The firm has an $85 target on the stock.
• FBR Capital upgraded Hyatt Hotels (H) to market perform from underperform following the company's Q2 results. The firm raised its target for shares to $44 from $38.
• BB&T upgraded to Smithfield Foods (SFD) to buy from hold, citing tighter supplies, strong pork prices and improving export demand. The firm has a $19 target on the stock.
• Holly (HOC) was upgraded to outperform from market perform at BMO Capital.
• Cogent Communications (CCOI) was upgraded to outperform from neutral at Cowen.
• Catalyst Health (CHSI) was upgraded to overweight from equal weight at First Analysis.

Analyst Upgrades

• Stifel views shares of DreamWorks (DWA) as oversold and believes investors are too pessimistic on recent films. The firm upgraded shares to buy from hold and has a $35 target on the stock.
• JPMorgan upgraded Consolidated Edison (ED) to neutral from underweight based on EPS visibility. The firm raised its price target to $45 from $37.
• Soleil upgraded PPL Corp. (PPL) to buy from hold following the 90M share secondary last night that was priced at $24. The firm sees improving earnings visibility and a removal of the equity overhang for the upgrade. The firm has a $29 price target on the stock.
• Unilever (UL) was upgraded to neutral from underperform at Credit Suisse.
• Holly (HOC) was upgraded to buy from neutral at BofA/Merrill.
• Bebe Stores (BEBE) was upgraded to neutral from underperform at Cowen.
• Oppenheimer upgraded Monster Worldwide (MWW) to outperform from perform.

Perhaps the European Union was doomed from the start and it just took a decade for the more productive member states to realize it.

If you went into a business with a bad partner is there any way for it to work? Inevitably there will be a split and that might be the case for the EU members and the battered euro.

Regardless of the end result shrewd investors should be on the lookout for stock bargains in large successful European companies undermined by the failure of the monetary system. The following three stocks are examples worth considering.

Analyst Upgrades

• Soleil upgraded Potash (POT) to hold from sell due to valuation. The firm maintains a $100 price target for shares.
• FBR Capital upgraded Arkansas Best (ABFS) to market perform from underperform after the company reached a tentative agreement with the Teamsters to amend its existing contract to include a 15% wage concession. The firm has a $34 price target for shares.
• Keefe Bruyette upgraded Zions Bancorp (ZION) to market perform from underperform following the company's Q1 results and raised its target for shares to $25 from $17.
• Apache (APA) was upgraded to outperform from neutral at Macquarie.
• MGM Mirage (MGM) wasupgraded to conviction buy from buy at Goldman.
• Monster Worldwide (MWW) was upgraded to outperform from neutral at Credit Suisse.

Analyst Upgrades

• Leerink upgraded Genzyme (GENZ) to outperform from market perform due to valuation as it believes the sell-off on news of the consent decree is overdone.
• FBR Capital upgraded Progressive (PGR) to outperform from market perform to reflect an improving outlook. The firm raised its target price for shares to $23 from $18.
• Janney Montgomery upgraded Cheesecake Factory (CAKE) two notches to buy from sell, citing improving casual-dining sales trends. The firm has a $30 price target for shares.
• Research in Motion (RIMM) was raised to overweight from neutral at JPMorgan.
• Tata Motors (TTM) was upgraded to buy from hold at Deutsche Bank.
• Palm (PALM) was upgraded to market perform from underperform at BMO Capital.

Consumer products giant Unilever (UL) saw big business even during the worst of the recession thanks to its recognizable brands like Ben & Jerry's, Vaseline and Cutex. This loyal customer base has provided a great backbone for the company's sales and profits, and kept this stock attractive among investors.

Now that consumer spending appears to be on the mend, Unilever is looking to take its business to the next level with a new line of men's products -- including Dove moisturizers and bath items.

Here are some highlights from this past week's earnings coverage on BloggingStocks:

• Aflac Inc. (AFL) posted better-than-expected Q4 earnings, though revenue fell short, and offered rosy guidance.
• Avon Products Inc. (AVP) posted Q4 earnings growth that met analysts' expectations but shares sold off.
• Cisco Systems inc. (CSCO) higher Q2 earnings topped the consensus estimate but cash flow fell.
• CME Group Inc. (CME) fell short of analysts' Q4 profit expectations, resulting in price-target cuts.
• ExxonMobil Corp. (XOM) posted better-than-expected Q4 earnings and revenue that boosted shares.

There have been no problems selling big-ticket ads for this weekend's broadcast of Super Bowl XLIV. And with good reason -- this has been one of the best years for football on television, with viewership up across the board. The recent NFC and AFC championship games were the NFL's largest combined audience for the two championship games since January 1982.

With all those eyeballs, the real winners could turn out to be the companies with the most aggressive (and the most memorable) advertising spots.

This week brought earnings results from three pantry stocks -- Clorox Co. (CLX), Kellogg Co. (K) and Unilever (UL). While Clorox's strong second-quarter earnings beat the consensus estimates of analysts polled by Thomson Reuters, Kellogg's lower fourth-quarter earnings fell short of expectations, and Unilever's earnings fell as well.

Clorox said net income totaled $110 million, or 77 cents per share, up from $86 million, or 61 cents a share, a year earlier. That was a penny per share better than the Street view. Revenue climbed 5% to $1.28 billion. Results benefited from fears over the H1N1 flu, favorable foreign exchange rates and lower commodity costs. Clorox, whose brands include PineSol, Hidden Valley, Glad and Kingsford, also raised its outlook for full-year earnings to a range of $4.10 to $4.25 per share, which is in line with expectations.